Eric Devroe

Chief Operating Officer, Acrivon Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Aug 18, 2026

Companies

Acrivon Therapeutics, Inc.Chief Operating Officer +$0.0M −$0.0M

Trades

ACRV Sold 604 shares at $2.01 $0.0M Aug 18

ACRV Bought 10,000 shares at $1.72 $0.0M Jan 13

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.